1 We investigated the efficacy and cost-effectiveness of outpat
2 We investigated the efficacy and safety of a low-Phe diet com
3 We investigated the efficacy and safety of a new topical fiel
4 We investigated the efficacy and safety of a skin-patch vacci
5 We investigated the efficacy and safety of adjuvant lapatinib
6 We investigated the efficacy and safety of drisapersen, a 2'-
7 We investigated the efficacy and safety of early hen's egg in
8 We investigated the efficacy and safety of endoscopic resecti
9 In this prespecified analysis of FOURIER,
we investigated the efficacy and safety of evolocumab by diab
10 We investigated the efficacy and safety of evolocumab in pati
11 On the basis of this unmet need,
we investigated the efficacy and safety of fedratinib, a JAK2
12 We investigated the efficacy and safety of GSK2330672, a sele
13 In this phase II study,
we investigated the efficacy and safety of liposomal amikacin
14 We investigated the efficacy and safety of naloxegol, an oral
15 We investigated the efficacy and safety of nicotine patches d
16 In this phase 3, randomized study,
we investigated the efficacy and safety of oral BG-12, at a d
17 We investigated the efficacy and safety of progesterone in a
18 We investigated the efficacy and safety of switching to a sin
19 We investigated the efficacy and safety of vosaroxin, a first
20 We investigated the efficacy and tolerability of MK-5172 with
21 Therefore,
we investigated the efficacy of a novel 'modular' anesthesia
22 We investigated the efficacy of a recombinant mouse protein c
23 We investigated the efficacy of a small molecule Gbetagamma i
24 We investigated the efficacy of a small molecule inhibitor of
25 nd the roles of CD4(+) T cells in the effects of adjuvants,
we investigated the efficacy of a T-dependent influenza virus
26 We investigated the efficacy of adalimumab for inducing and m
27 We investigated the efficacy of allele-specific silencing by
28 Here,
we investigated the efficacy of an engineered bacterium expre
29 Here
we investigated the efficacy of bacteriophage-therapy (phage)
30 Here,
we investigated the efficacy of calcipotriol, a topical TSLP
31 Here
we investigated the efficacy of CD11b or Ly-6C/Ly-6G-specific
32 In this multicentre, open-label, phase 3 study,
we investigated the efficacy of cilengitide in patients from
33 We investigated the efficacy of cixutumumab, a fully human Ig
34 We investigated the efficacy of combined simeprevir and sofos
35 We investigated the efficacy of electroacupuncture in reducin
36 In the present study,
we investigated the efficacy of fenofibrate (Tricor), a pan-P
37 Here,
we investigated the efficacy of in situ, nonchemical UV treat
38 We investigated the efficacy of indole-3-carbinol (I3C), a di
39 Because this neurotoxicity involves ROS production,
we investigated the efficacy of mangafodipir, a molecule that
40 We investigated the efficacy of mesalamine in preventing recu
41 We investigated the efficacy of metabolomics for field-monito
42 Therefore,
we investigated the efficacy of noninvasive microcomputed tom
43 We investigated the efficacy of oral single-dose azithromycin
44 We investigated the efficacy of resveratrol (RESV) for preven
45 We investigated the efficacy of specific human monoclonal ant
46 We investigated the efficacy of the addition of ezetimibe to
47 by which RAGE influences COPD in experimental COPD models,
we investigated the efficacy of the RAGE-specific antagonist
48 We investigated the efficacy of these NP adjuvants in inducin
49 We investigated the efficacy,
safety, and tolerability of swi
50 We investigated the efficacy,
tolerability, and pharmacokinet